[1] |
Aggarwal A,Puri K,Liangpunsakul S.Deep vein thrombosisand pulmonary embolism in cirrhotic patients:system aticre view[J].World Gastroenterol,2014,20(19):5737-5745.
|
[2] |
Stine JG,Shah PM,Cornella SL,et al.Portal vein thrombosis,mortality and hepatic decompensation in patients with cirrhosis:a meta-analysis[J].World J Hepatol,2015,7(27):2774-2780.
|
[3] |
Qi X,Han G,Wu K,et al.Antieoagulation for portal vein thrombosis in cirrhosis[J].Am J Med,2010,123(9):19-20.
|
[4] |
Chawla Y,Duseja A,Dhiman PK.Review aticle:the modern management of portal vein thrombosis[J].Aliment Pharmacol Ther,2009,30(9):881-894.
|
[5] |
DeLeve LD,Valla DC,Garcia-Tsao G.American association for the study liver diseases vascular disorders of the liver[J].Hepatology,2009,49(5):1729-1764.
|
[6] |
Loffredo L,Pastori D,Farcomeni A,et al.Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis:a systematic review and Meta-analysis[J].Gastroenterology,2017,153(2):480-487.
|
[7] |
Tonon M,Piano S,Sacerdoti D,et al.Efficacy and safety of treatment of acute nonmalignant portal vein thrombosis with subcutaneous fondaparinux in patients with cirrhosis and marked thrombocytopenia[J].Dig Liver Dis,2016,48(1):25-26.
|
[9] |
臧立娜,李晓峰.肝硬化并非门静脉血栓研究进展[J].实用肝脏病杂志,2014,17(4):429-432.
|
[18] |
Martinelli I,Franchini M,Mannucci PM.How I treat rare venous thromboses[J].Blood,2008,112(13):4818-4823.
|
[8] |
European Association for the Study of the Liver.EASL clinical practice guidelines:vascular diseases of the liver[J].Hepatology,2016,64(1):179-202.
|
[10] |
Senzolo M,Sartori T,Rossetto V,et al.Prospective evalnation of anticoagulation and transjugular intrahcpatic portosystemic shunt for the management of portal vem thrombosis in cirrhosis[J].Liver Int,2012,32(6):919-927.
|
[11] |
Turnes J,García-Pagan JC,Gonzalez M,et al.Portal hypertension related complications after acute portal vein throm-bosis:impact of early anticoagulation[J].Clin Gastroenterol Hepatol,2008,6(12):1412-1417.
|
[12] |
Loffredo L,Pastori D,Farcomeni A,et al.Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis:a systematic review and Meta-analysis[J].Gastroenterology,2017,153(2):480-487.
|
[13] |
Qi XS,Valerio DS.Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis:a systematic review and meta-analysis of observational studies[J].Eur J Int Med,2015,26(12):23-29.
|
[14] |
Dolovich LR,Ginsberg JS,Douketis JD,et al.A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism:examining some unanswered questions regarding location of treatment,product type,and dosing frequency[J].Arch Intern Med,2000,160(2):181-188.
|
[15] |
Under the auspices of the Italian Association for the Study of Liver Diseases(AISF) and the Italian Society of Internal Medicine(SIMI).Hemostatic balance in patients with liver cirrhosis:report of a consensus conference[J].Dig Liver Dis,2016,48(5):455-467.
|
[16] |
Condat B,Pessione F,Hillaire S,et al.Current outcome of portalvein thrombosis in adults:risk and benefit of anticoagulant therapy[J].Gastroenterology,2001,120(2):490-497.
|
[17] |
Spaander MCW,Hekstra J,Hansen BE,et al.Anticoagulant therapy in patients with noncirrhotic portal vein thrombosis:effect on new thrombotic events and gastrointestinal bleeding[J].Thromb Haemost,2013,11(3):452-459.
|
[19] |
Plessier A,Murad SD,Guerra MH.Acute portal vein thrombosis unrelated to cirrhosis:aprospective multicenter follow-up study[J].Hepatology,2010,51(1):210-218.
|
[20] |
Belnap L,Rodgers GM,Cottam D,et al.Portal mesentericvein thrombosis after laparoscopic sleeve gastrectomy:presentationandmanagemen[J].SurgObesRelat Dis,2016,12(10):1787-1794.
|
[21] |
Villa E,Camma C,Marietta M,et al.Enoxaparin prevents poetal vein thrombosis and liver decompensation in patients with advanced cirrhosis[J].Gastroenterology,2012,143(5):1253-1256.
|
[22] |
Tripodi A,Anstee QM,Sogaard KK,et al.Hypercoagulability in cirrhosis:causes and consequences[J].Thromb Haemost,2011,9(9):1713-1723.
|
[23] |
易有峰,王晓娟,陈有元.肝硬化患者凝血指标检测的临床意义[J].中国肝脏病杂志(电子版),2010,2(3):28-29.
|
[24] |
De Santis A,Moscatelli R,Catalano C,et al.Systemic thrombolysis of portal vein thrombosis in cirrhotic patients:a pilot study[J].Dig Liver Dis,2010,42(6):451-455.
|
[25] |
Bartley T,Kush D.Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis:technical considerations[J].Tech Vasc Intervent,Radiol,2016,19(1):52-60.
|
[26] |
Han G,Qi X,He C,et al.Transjugular intrahepatic portosystemic shunt or Portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis[J].Hepatology,2011,5(1):78-88.
|
[27] |
Stine JG,Wang J,Shah PM,et al.Decreased portal vein velocity is predictive of the development of portal vein thrombosis:A matched case-control study[J].Liver Int,2018,38(1):94-101.
|
[28] |
Qi X,He C,Guo W,et al.Transjugular intrahepatic porto systemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis:outcomes and predictors in a prospective cohort study[J].Liver Int,2016,36(5):667-676.
|